Six molecules·76 trial records·6 deals·21 calls on the record
Drug companies are spending billions on psychedelic medicine, mostly in America.
We read the contracts and filings behind every deal to show what's been bought, what's been skipped, and what that leaves open in Europe.
Free. One email, Tuesday 11:00. Unsubscribe in one click.
Six molecules will decide what Europe gets. We follow all of them, every week.
For the 21 million people in the EU living with depression.
The money
$8.2bn
Headline value of the six deals we track. Lilly, AbbVie, Otsuka. None of it European.
Where Europe stands
Twelve assets. Six molecules. Four with no European partner.
Every row from a filing or a registry. Stage is the highest with a European record; US progress is a note, never a position.
| Molecule | Asset | Holder | Stage in Europe | European partner | Bought | Source |
|---|---|---|---|---|---|---|
| Psilocybin | COMP360 | Compass Pathways | Phase 3 | None disclosed | · | 10-K · 25 Aug |
| Lysergide | DT120 | Definium Therapeutics | Phase 3 | None disclosed | · | 10-K · 15 Sep |
| Mebufotenin | BPL-003 | Lilly, via AtaiBeckley | Phase 2 | Lilly | $3.8bn · Sep 2026 | 8-K · 15 Sep |
| GH001 | GH Research | Phase 2 | None disclosed | · | 20-F · 25 Aug | |
| HLP003 | HLP003 | Helus Pharma | Phase 3 | None disclosed | · | AIF · 24 Aug |
| MDMA | Amsterdam UMC | Investigator-led | Phase 2 | n/a | · | CTIS · 8 Sep |
| Brenipatide | LY3537031 | Lilly | Phase 3 | Lilly | · | 10-Q · 15 Sep |
Issue 22·10 November 2026
EMBRACE has halted in every EU country where it started.
CTIS logs a temporary halt for the HLP003 Phase 3 in Poland, Greece and Ireland, dated 28 September, the day recruitment ended. The sponsor's justification: "Temporary interruption in IP supply, not quality related". Our call: no restart by 31 March.
Read the issueFor funds and corporate development teams: the Deal Read, 1,500 EUR. First page in 48 hours.
The call in this issue
EMBRACE will not restart in Poland, Greece or Ireland by 31 March 2027.
Open · resolves by 31 Mar 2027 · scored in the first May issue
Falsifier: CTIS shows RESTART_OF_TRIAL or RESTART_OF_RECRUITMENT for Poland, Greece or Ireland on record 2024-519270-40-00, with an event date on or before 31 March 2027, as published in CTIS when read on 30 April 2027